Cambridge Oncology Seminar Series
This Seminar series is being developed to cover clinical, laboratory and translational aspects of cancer.
It is being organised jointly by members of the Cambridge Research Institute, Clinical, Medical and Surgical Oncology and the Hutchison/MRC Research Centre.
In addition to external speakers, group leaders from each of the Departments will give presentations, and in the main, each session will involve at least two speakers.
The talks are open to all interested persons from the University of Cambridge, Cancer Research UK and Addenbrooke's Hospital. Members of the local pharma and biotechnology companies are also welcome to attend by prior arrangement with Laura Blackburn.
The talks are held weekly at 12 noon in the Alice Fisher Lecture Theatre, S Block, Addenbrooke's Hospital. A buffet lunch (sponsored by Pfizer Oncology) will be served outside the lecture theatre after seminar.
| 10 June 2008 | Mechanisms of tamoxifen action and resistance Jason Carroll Cambridge Research Institute and Cambridge Oncology - past, present and future David Gilligan Addenbrooke's Hospital Host: John Kelly |
| 17 June 2008 | Using Bayesian analysis in randomised phase II clinical trials to determine the worth of proceeding to phase III Cindy Billingham University of Birmingham Host: To be confirmed |
| 24 June 2008 | Title to be confirmed Gill Murphy Cambridge Research Institute and Department of Oncology and Title to be confirmed Charles Wilson Addenbrooke's Hospital Host: To be confirmed |
